Article in Journal of fungi (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 49% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 4 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors at 3 institutions in 2 countries.
Prashant Kumar MauryaChromatin Remodelling Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi 110067, India.
Pramita GaraiChromatin Remodelling Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi 110067, India.
Kaveri GoelChromatin Remodelling Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi 110067, India.
Himanshu BhattChromatin Remodelling Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi 110067, India.
Anindita DuttaChromatin Remodelling Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi 110067, India.
Aarti GoyalChromatin Remodelling Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi 110067, India.
Sakshi DewasthaleChromatin Remodelling Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi 110067, India.
Meghna GuptaDepartment of Biochemistry and Biophysics, University of California, San Francisco, CA 94158, USA.ORCID 0000-0002-7432-3211
Dominic Thangminlen HaokipDepartment of Botany, United College, Chandel, Manipur University, Mizoram 795172, India.ORCID 0000-0003-3405-8262
Sanju BarikChromatin Remodelling Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi 110067, India.
Rohini MuthuswamiChromatin Remodelling Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi 110067, India.ORCID 0000-0002-0559-9484
Jawaharlal Nehru University · INManipur University · INUniversity of California, San Francisco · US
Funding
Department of Biotechnology BT/PR28600/BRB/10/1678/2018University Grants Commission No.F. 2-3/2014-15(Policy MRP); (MRP ID: MRP-Major-BIOC-2013-24744)
6 · The paper itself
Abstract
Fun30, an ATP-dependent chromatin remodeler from
Indexed as
C. albicanschromatin remodelingDNA damage responseFun30Rtt109
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Fun30 and Rtt109 Mediate Epigenetic Regulation of the DNA Damage Response Pathway in · full record | OpenQuestion